MRMD Stock Overview
MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
MariMed Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.27 |
| 52 Week High | US$0.55 |
| 52 Week Low | US$0.20 |
| Beta | 2.87 |
| 1 Month Change | 2.53% |
| 3 Month Change | -20.95% |
| 1 Year Change | -32.18% |
| 3 Year Change | -63.89% |
| 5 Year Change | -91.23% |
| Change since IPO | -33.20% |
Recent News & Updates
Recent updates
Shareholder Returns
| MRMD | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -3.4% | -0.6% | 1.0% |
| 1Y | -32.2% | 10.6% | 21.9% |
Return vs Industry: MRMD underperformed the US Pharmaceuticals industry which returned 13.2% over the past year.
Return vs Market: MRMD underperformed the US Market which returned 24.9% over the past year.
Price Volatility
| MRMD volatility | |
|---|---|
| MRMD Average Weekly Movement | 11.3% |
| Pharmaceuticals Industry Average Movement | 9.7% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: MRMD's share price has been volatile over the past 3 months.
Volatility Over Time: MRMD's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 682 | Jon Levine | www.marimedinc.com |
MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature’s Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand.
MariMed Inc. Fundamentals Summary
| MRMD fundamental statistics | |
|---|---|
| Market cap | US$101.37m |
| Earnings (TTM) | -US$16.03m |
| Revenue (TTM) | US$148.60m |
0.7x
P/S Ratio-6.3x
P/E RatioIs MRMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MRMD income statement (TTM) | |
|---|---|
| Revenue | US$148.60m |
| Cost of Revenue | US$82.68m |
| Gross Profit | US$65.92m |
| Other Expenses | US$81.95m |
| Earnings | -US$16.03m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 08, 2024
| Earnings per share (EPS) | -0.042 |
| Gross Margin | 44.36% |
| Net Profit Margin | -10.79% |
| Debt/Equity Ratio | 74.7% |
How did MRMD perform over the long term?
See historical performance and comparison